Viyash Scientific Limited — PPTs, 19-05-2026: Investor Presentation

Here's a summary of Viyash Scientific's investor presentation, tailored for retail investors:

**1. Business Performance:**

Viyash Scientific delivered a strong FY26, with Q4 being its best quarter ever. Revenues grew 13.8% YoY to ₹34,203 Cr for the full year, driven by robust performance in Formulations (+18% YoY) and APIs (+8% YoY). Key growth geographies include Europe (+19% YoY) and Emerging Markets (+23% YoY).

**2. Growth Drivers or Strategy:**

The company is focused on realizing synergies from its recent integration, which has improved operational efficiency and resilience. They are actively evaluating inorganic opportunities to further strengthen their platform.

**3. Recent Developments:**

The merger process is complete and in effect. Viyash is now focused on synergy realization, which is well on track.

**4. Key Financial Metrics:**

For FY26, Revenue stood at ₹34,203 Cr, a 13.8% YoY increase. EBITDA grew by 59.6% YoY to ₹7,025 Cr. Net Debt to LTM EBITDA improved significantly to 0.2x from 1.0x in FY25.

**5. Management Commentary / Outlook:**

Management is excited about the product pipeline and growth roadmap for FY27. With a deleveraged balance sheet, they are strategically positioned to pursue growth and create long-term value.